Related Experiment Video
Updated: Apr 25, 2026
Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury
Jo-Wen Liu1, Manuel Montero, Liming Bu
1Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, California, USA.
Insights
Epidermal fatty acid-binding protein (E-FABP) protects nerve cells from fatty acid overload by reducing reactive oxygen species (ROS). This finding offers potential therapeutic strategies for conditions like Type 2 diabetes neuropathy.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- Epidermal fatty acid-binding protein (E-FABP) transports fatty acids and may protect against neuronal injury.
- Lipotoxic injury from fatty acid overload is a concern in neurological conditions.
Purpose of the Study:
- To investigate whether E-FABP protects nerve growth factor-differentiated PC12 cells (NGFDPC12 cells) from palmitic acid-induced lipotoxicity.
- To elucidate the mechanisms underlying E-FABP's protective effects against lipotoxic injury.
Main Methods:
- NGFDPC12 cells were treated with palmitic acid (PAM) to induce lipotoxicity.
- E-FABP levels, reactive oxygen species (ROS) production, and apoptosis were measured.
- Gene silencing (siE-FABP) and recombinant E-FABP were used to manipulate E-FABP levels.
- PPAR agonists were employed to study E-FABP regulation.
Main Results:
- Palmitic acid overload induced lipotoxicity, apoptosis, ROS accumulation, and increased E-FABP levels in NGFDPC12 cells.
- Antioxidants reduced E-FABP induction, while tert-butyl hydroperoxide increased both ROS and E-FABP.
- siE-FABP treatment exacerbated ROS and cell death, whereas increased E-FABP levels diminished PAM-induced damage.
- PPAR agonists enhanced E-FABP expression and cell resistance to lipotoxicity.
Conclusions:
- E-FABP protects NGFDPC12 cells from lipotoxic injury by reducing ROS.
- E-FABP may serve as a therapeutic target for preventing nerve cell damage in conditions involving free fatty acid overload, such as Type 2 diabetes neuropathy.
Abstract:
Epidermal fatty acid-binding protein (E-FABP/FABP5/DA11) binds and transport long-chain fatty acids in the cytoplasm and may play a protecting role during neuronal injury. We examined whether E-FABP protects nerve growth factor-differentiated PC12 cells (NGFDPC12 cells) from lipotoxic injury observed after palmitic acid (C16:0; PAM) overload. NGFDPC12 cells cultures treated with PAM/bovine serum albumin at 0.3 mM/0.15 mM show PAM-induced lipotoxicity (PAM-LTx) and apoptosis. The apoptosis was preceded by a cellular accumulation of reactive oxygen species (ROS) and higher levels of E-FABP. Antioxidants MCI-186 and N-acetyl cysteine prevented E-FABP's induction in expression by PAM-LTx, while tert-butyl hydroperoxide increased ROS and E-FABP expression. Non-metabolized methyl ester of PAM, methyl palmitic acid (mPAM), failed to increase cellular ROS, E-FABP gene expression, or trigger apoptosis. Treatment of NGFDPC12 cultures with siE-FABP showed reduced E-FABP levels correlating with higher accumulation of ROS and cell death after exposure to PAM. In contrast, increasing E-FABP cellular levels by pre-loading the cells with recombinant E-FABP diminished the PAM-induced ROS and cell death. Finally, agonists for PPARβ (GW0742) or PPARγ (GW1929) increased E-FABP expression and enhanced the resistance of NGFDPC12 cells to PAM-LTx. We conclude that E-FABP protects NGFDPC12 cells from lipotoxic injury through mechanisms that involve reduction of ROS. Epidermal fatty acid-binding protein (E-FABP) may protect nerve cells from the damaging exposure to high levels of free fatty acids (FA). We show that E-FABP can neutralize the effects of reactive oxygen species (ROS) generated by the high levels of FA in the cell and protect PC12 cells from lipotoxic injuries common in Type 2 diabetes neuropathy. Potentially, E-FABP gene up-regulation may be mediated through the NFkB pathway and future studies are needed to further evaluate this proposition.
